Junko Satoh

1.5k total citations
41 papers, 1.2k citations indexed

About

Junko Satoh is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Junko Satoh has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Junko Satoh's work include Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Junko Satoh is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Junko Satoh collaborates with scholars based in Japan, United States and Germany. Junko Satoh's co-authors include Shinji Ito, Ko Kato, Atsuhiko Shinmyō, Akiko Furuya, Toshihiko Fujimori, Yo‐ichi Nabeshima, Yoko Nabeshima, Frank J. Gonzalez, Chi Chen and Fumitaka Suzuki and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Junko Satoh

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junko Satoh Japan 19 578 279 231 131 126 41 1.2k
Yoshihiro Mezaki Japan 14 377 0.7× 160 0.6× 175 0.8× 110 0.8× 87 0.7× 41 838
Yanchun Li China 17 420 0.7× 197 0.7× 76 0.3× 77 0.6× 64 0.5× 56 952
Huafeng Wang China 18 468 0.8× 290 1.0× 128 0.6× 80 0.6× 46 0.4× 30 1.1k
Frank Staib Germany 15 763 1.3× 310 1.1× 236 1.0× 55 0.4× 62 0.5× 37 1.4k
J. Gu China 9 578 1.0× 369 1.3× 179 0.8× 31 0.2× 74 0.6× 12 1.0k
Xilong Wang China 19 553 1.0× 103 0.4× 73 0.3× 108 0.8× 102 0.8× 86 1.1k
Hyun Jin Bae South Korea 24 1.2k 2.1× 242 0.9× 55 0.2× 42 0.3× 68 0.5× 44 1.9k
Peter Ove United States 24 894 1.5× 199 0.7× 277 1.2× 93 0.7× 176 1.4× 54 1.7k
Weiping Zhu China 19 435 0.8× 76 0.3× 84 0.4× 102 0.8× 29 0.2× 53 916
Kunwar Shailubhai United States 22 625 1.1× 116 0.4× 82 0.4× 31 0.2× 93 0.7× 59 1.5k

Countries citing papers authored by Junko Satoh

Since Specialization
Citations

This map shows the geographic impact of Junko Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Satoh more than expected).

Fields of papers citing papers by Junko Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Satoh. The network helps show where Junko Satoh may publish in the future.

Co-authorship network of co-authors of Junko Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Satoh. A scholar is included among the top collaborators of Junko Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Satoh. Junko Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takasugi, Masaki, Yuya Yoshida, Frank Stein, et al.. (2024). An atlas of the aging mouse proteome reveals the features of age-related post-transcriptional dysregulation. Nature Communications. 15(1). 8520–8520. 11 indexed citations
2.
Nakayama, Yoichi, Mirei Shirakashi, Ran Nakashima, et al.. (2024). Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus. Lara D. Veeken. 64(5). 3104–3115.
3.
Nozawa, Takashi, Atsuko Minowa‐Nozawa, Junko Satoh, et al.. (2023). Rab41-mediated ESCRT machinery repairs membrane rupture by a bacterial toxin in xenophagy. Nature Communications. 14(1). 6230–6230. 5 indexed citations
4.
5.
Hakuno, Daihiko, Masahiro Kimura, Shinji Ito, et al.. (2018). Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction. Scientific Reports. 8(1). 16749–16749. 12 indexed citations
6.
Nakabo, Shuichiro, Motomu Hashimoto, Shinji Ito, et al.. (2017). Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. Lara D. Veeken. 56(7). 1217–1226. 26 indexed citations
7.
Shirane, Kenjiro, Kazuki Kurimoto, Yukihiro Yabuta, et al.. (2016). Global Landscape and Regulatory Principles of DNA Methylation Reprogramming for Germ Cell Specification by Mouse Pluripotent Stem Cells. Developmental Cell. 39(1). 87–103. 101 indexed citations
8.
Ito, Shinji, Junko Satoh, Tsutomu Matsubara, et al.. (2013). Cholestasis induces reversible accumulation of periplakin in mouse liver. BMC Gastroenterology. 13(1). 116–116. 5 indexed citations
9.
Suzuki, Fumitaka, Norio Akuta, Yoshiyuki Suzuki, et al.. (2006). Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants. Journal of Medical Virology. 78(3). 341–352. 18 indexed citations
10.
Suzuki, Fumitaka, Yoshiyuki Suzuki, Norio Akuta, et al.. (2005). A novel entecavir-resistant virus with patient of lamivudine-resistant hepatitis B virus mutant. Kanzo. 46(8). 523–523. 1 indexed citations
11.
Suzuki, Fumitaka, Akihito Tsubota, Yasuji Arase, et al.. (2004). Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis. Journal of Gastroenterology. 39(11). 1078–1084. 9 indexed citations
12.
Suzuki, Fumitaka, Y Arase, Yoshiyuki Suzuki, et al.. (2004). Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. Journal of Viral Hepatitis. 11(3). 271–276. 59 indexed citations
13.
Matsuda, Marie, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.. (2004). YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine. Journal of Medical Virology. 74(2). 361–366. 28 indexed citations
14.
Satoh, Junko, Ko Kato, & Atsuhiko Shinmyō. (2004). The 5′-untranslated region of the tobacco alcohol dehydrogenase gene functions as an effective translational enhancer in plant. Journal of Bioscience and Bioengineering. 98(1). 1–8. 72 indexed citations
15.
Aoki, Yasuko, et al.. (2003). Targeted Bacteremia Surveillance Throughout a Year. Kansenshogaku zasshi. 77(4). 211–218. 2 indexed citations
16.
Kato, Ko, et al.. (2003). 5′ Untranslated region of theHSP18.2 gene contributes to efficient translation in plant cells. Journal of Bioscience and Bioengineering. 95(1). 52–58. 21 indexed citations
17.
Suzuki, Fumitaka, Akihito Tsubota, Yasuji Arase, et al.. (2003). Efficacy of Lamivudine Therapy and Factors Associated with Emergence of Resistance in Chronic Hepatitis B Virus Infection in Japan. Intervirology. 46(3). 182–189. 72 indexed citations
18.
Suzuki, Fumitaka, Akihito Tsubota, Yasuji Arase, et al.. (2003). HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B. Journal of Medical Virology. 70(3). 355–360. 2 indexed citations
19.
Satoh, Junko, Kyoko Baba, Yoichi Nakahira, et al.. (1999). Developmental stage‐specific multi‐subunit plastid RNA polymerases (PEP) in wheat. The Plant Journal. 18(4). 407–415. 38 indexed citations
20.
Shimizu, Toshio, et al.. (1995). Estramustine Phosphate forPreventing Flare-Up in LuteinizingHormone-Releasing HormoneAnalogue Depot Therapy. European Urology. 27(3). 192–195. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026